Related references
Note: Only part of the references are listed.Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Franco De Crescenzo et al.
LANCET (2022)
Comparative efficacy and safety of hypnotics for insomnia in older adults: a systematic review and network meta-analysis
Hsiao-Yean Chiu et al.
SLEEP (2021)
Evaluation of the Consensus Sleep Diary in a community sample: comparison with single-channel electroencephalography, actigraphy, and retrospective questionnaire
Jessica R. Dietch et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2021)
Insomnia, anxiety, and depression during the COVID-19 pandemic: an international collaborative study
Charles M. Morin et al.
SLEEP MEDICINE (2021)
Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder
Yves Dauvilliers et al.
ANNALS OF NEUROLOGY (2020)
Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis
Sean McGrath et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2020)
Lemborexant vs suvorexant for insomnia: A systematic review and network meta-analysis
Taro Kishi et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2020)
Efficacy, acceptability, and tolerability of all available treatments for insomnia in the elderly: a systematic review and network meta-analysis
M. T. Samara et al.
ACTA PSYCHIATRICA SCANDINAVICA (2020)
Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2
Mikko Karppa et al.
SLEEP (2020)
Pain inconsistency and sleep in mid to late-life: the role of depression
Scott G. Ravyts et al.
AGING & MENTAL HEALTH (2019)
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update
Sue Wilson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder A Phase 3 Randomized Clinical Trial
Russell Rosenberg et al.
JAMA NETWORK OPEN (2019)
Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline
Michael J. Sateia et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2017)
Time Trends in the Family Physician Management of Insomnia: The Australian Experience (2000-2015)
Christopher B. Miller et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2017)
European guideline for the diagnosis and treatment of insomnia
Dieter Riemann et al.
JOURNAL OF SLEEP RESEARCH (2017)
Cognitive Behavioral Insomnia Therapy for Those With Insomnia and Depression: A Randomized Controlled Clinical Trial
Colleen E. Carney et al.
SLEEP (2017)
Australasian Sleep Association position statement regarding the use of psychological/behavioral treatments in the management of insomnia in adults
Melissa Ree et al.
SLEEP MEDICINE (2017)
Suvorexant for the treatment of primary insomnia: A systematic review and meta-analysis
Akira Kuriyama et al.
SLEEP MEDICINE REVIEWS (2017)
Cognitive Behavioral Insomnia Therapy for Those With Insomnia and Depression: A Randomized Controlled Clinical Trial
Colleen E. Carney et al.
SLEEP (2017)
Efficacy and Safety of 6-Month Nightly Ramelteon Administration in Adults with Chronic Primary Insomnia
SLEEP (2017)
Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2016)
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
W. Joseph Herring et al.
BIOLOGICAL PSYCHIATRY (2016)
The STAR*D Trial: It Is Time to Reexamine the Clinical Beliefs That Guide the Treatment of Major Depression
H. Edmund Pigott
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2015)
Effect of Placebo Conditions on Polysomnographic Parameters in Primary Insomnia: A Meta-Analysis
Alexander Winkler et al.
SLEEP (2015)
The Nature of Stable Insomnia Phenotypes
Vivek Pillai et al.
SLEEP (2015)
Doxepin for insomnia: A systematic review of randomized placebo-controlled trials
Wing-Fai Yeung et al.
SLEEP MEDICINE REVIEWS (2015)
Effect of Placebo Conditions on Polysomnographic Parameters in Primary Insomnia: A Meta-Analysis
Alexander Winkler et al.
SLEEP (2015)
The Nature of Stable Insomnia Phenotypes
Vivek Pillai et al.
SLEEP (2015)
A Randomized Controlled Trial of Mindfulness Meditation for Chronic Insomnia
Jason C. Ong et al.
SLEEP (2014)
Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis
Akira Kuriyama et al.
SLEEP MEDICINE (2014)
Review of the histamine system and the clinical effects of H1 antagonists: Basis for a new model for understanding the effects of insomnia medications
Andrew D. Krystal et al.
SLEEP MEDICINE REVIEWS (2013)
Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia
Alan Lankford et al.
SLEEP MEDICINE (2012)
Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia
Masako Kohsaka et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2011)
Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study
Naohisa Uchimura et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2011)
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
Gordon Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia
Makoto Uchiyama et al.
SLEEP MEDICINE (2011)
Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs - A randomized, placebo-controlled trial
Jennifer R. Glass et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
The efficacy and safety of drug treatments for chronic insomnia in adults: A meta-analysis of RCTs
Nina Buscemi et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2007)
Comparison of sleep condition and sleep-related psychological activity after cognitive-behavior and pharmacological therapy for chronic insomnia
Rengang Wu et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2006)
Sustained efficacy of eszopiclone over 6 months of nightly treatment: Results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia
AD Krystal et al.
SLEEP (2003)
Validation of the Insomnia Severity Index as an outcome measure for insomnia research
Celyne H. Bastien et al.
SLEEP MEDICINE (2001)
Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomnia
CL Drake et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2000)
A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia
James K. Walsh et al.
SLEEP MEDICINE (2000)
Share Paper
